Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

147.43 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 227
Open 147.43
Bid (Size) 146.61 (1)
Ask (Size) 148.00 (1)
Prev. Close 147.43
Today's Range 147.43 - 147.43
52wk Range 130.96 - 168.11
Shares Outstanding N/A
Dividend Yield 4.02%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Check Out What Whales Are Doing With ABBV
Via Benzinga
3 Top Stocks to Buy in October and Hold Forever
Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity. 
Via The Motley Fool

Performance

YTD
-9.21%
-9.21%
1 Month
+0.91%
+0.91%
3 Month
+7.13%
+7.13%
6 Month
-7.73%
-7.73%
1 Year
+6.59%
+6.59%

More News

Read More
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
Via The Motley Fool
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
Via InvestorPlace
What 4 Analyst Ratings Have To Say About AbbVie
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
Via Benzinga
AbbVie Unusual Options Activity
Via Benzinga
How Is The Market Feeling About AbbVie?
Via Benzinga
3 Magnificent Dividend Stocks to Buy in October
Via The Motley Fool
AbbVie's Promising Leap Towards Long-Term Growth: Analyst
Via Benzinga
AbbVie's Leukemia Drug Falls Short In Late-Stage Study In Pretreated Blood Cancer Patients
Via Benzinga
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years
Via The Motley Fool
Three Of Our Top Picks For Your Healthcare Portfolio
Via Talk Markets
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Via Benzinga
Clorox Pullback Presents a Chance to Clean Up on a 3.6% Dividend
Via MarketBeat
Argenx's 28% Surge & Promising Product Propel Investor Confidence
Via MarketBeat
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Only 7 Large-Cap Dividend Kings Yield Over 3%. Here's My Top Pick to Buy Now.
Via The Motley Fool
Flee to Healthcare Stocks if Recession Rears its Head?
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Former IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke
Via Investor's Business Daily
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
Via InvestorPlace
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
Via FinancialNewsMedia
Topics Economy
Exposures Economy Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.